Melenhorst; Jan J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Melenhorst; Jan J..The latest application filed is for "biomarkers for evaluating car-t cells to predict clinical outcome".

Company Profile

9.3.23

Melenhorst; Jan J. - Cherry Hill NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biomarkers For Evaluating Car-t Cells To Predict Clinical Outcome App 20210396739 - Pruteanu-Malinici; Iulian ; et al.	2021-12-23
Methods For Improving The Efficacy And Expansion Of Immune Cells App 20210246423 - Bedoya; Felipe ; et al.	2021-08-12
Therapeutic Regimens For Chimeric Antigen Receptor (car)- Expressing Cells App 20210177896 - Porter; David L. ; et al.	2021-06-17
Biomarkers Predictive Of Therapeutic Responsiveness To Chimeric Antigen Receptor Therapy And Uses Thereof App 20210172020 - Bedoya; Felipe ; et al.	2021-06-10
Car T Cell Therapies With Enhanced Efficacy App 20210047405 - Nobles; Christopher Loren ; et al.	2021-02-18
Methods Of Making Chimeric Antigen Receptor-expressing Cells App 20200370012 - Fraietta; Joseph A. ; et al.	2020-11-26
Bcma-targeting Chimeric Antigen Receptor, And Uses Thereof App 20200371091 - Pruteanu-Malinici; Iulian ; et al.	2020-11-26
Methods for improving the efficacy and expansion of immune cells Grant 10,829,735 - Bedoya , et al. November 10, 2	2020-11-10
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof Grant 10,774,388 - Bedoya , et al. Sept	2020-09-15
Biomarkers And Car T Cell Therapies With Enhanced Efficacy App 20200087376 - Fraietta; Joseph A. ; et al.	2020-03-19
Methods Of Making Chimeric Antigen Receptor - Expressing Cells App 20190292257 - Bedoya; Felipe ; et al.	2019-09-26
Combination Therapies Of Chimeric Antigen Receptors And Pd-1 Inhibitors App 20190151365 - Anak; Oezlem ; et al.	2019-05-23
Methods of making chimeric antigen receptor-expressing cells Grant 10,273,300 - Bedoya , et al.	2019-04-30
Car T Cell Therapies With Enhanced Efficacy App 20180258149 - Motz; Gregory ; et al.	2018-09-13
Biomarkers Predictive Of Cytokine Release Syndrome App 20180252727 - Garfall; Alfred ; et al.	2018-09-06
Methods For Improving The Efficacy And Expansion Of Chimeric Antigen Receptor?expressing Cells App 20180133296 - Barrett; David Maxwell ; et al.	2018-05-17
Biomarkers Predictive Of Therapeutic Responsiveness To Chimeric Antigen Receptor Therapy And Uses Thereof App 20170306416 - Bedoya; Felipe ; et al.	2017-10-26
Methods For Improving The Efficacy And Expansion Of Immune Cells App 20170137783 - Bedoya; Felipe ; et al.	2017-05-18
Methods Of Making Chimeric Antigen Receptor -expressing Cells App 20160185861 - Bedoya; Felipe ; et al.	2016-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.